Autobio Diagnostics Co., Ltd. (SHA:603658)
36.18
-0.09 (-0.25%)
Feb 13, 2026, 3:00 PM CST
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 20.67 billion as of February 13, 2026. Its market cap has decreased by -9.93% in one year.
Market Cap
20.67B
Enterprise Value
19.96B
Revenue
4.22B
Ranking
n/a
PE Ratio
18.86
Stock Price
36.18
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 20.67B, an increase of 134.40%. That is a compound annual growth rate of 9.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 20.67B | 2.15% |
| Dec 31, 2025 | 20.24B | -18.93% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| APT Medical | 33.37B |
| Lepu Medical Technology (Beijing) | 32.48B |
| MGI Tech | 27.67B |
| Double Medical Technology | 19.46B |
| MeHow Innovative | 18.12B |
| Shandong Weigao Blood Purification Products | 17.04B |
| Jafron Biomedical | 15.52B |
| Beijing Balance Medical Technology | 13.90B |